|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Deferred offering cost | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment: | ||||||||||||||||||||
| Machinery and equipment | ||||||||||||||||||||
| Less: accumulated depreciation | ||||||||||||||||||||
| Net property and equipment | ||||||||||||||||||||
| Other assets: | ||||||||||||||||||||
| Patents, net of amortization of $32,491 and $30,224, respectively | ||||||||||||||||||||
| Deposit | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Mezzanine: | ||||||||||||||||||||
| Series C Convertible Preferred Stock, 34,461 and 34,853 shares outstanding, respectively | ||||||||||||||||||||
| Series C Convertible Preferred Stock | ||||||||||||||||||||
| Total series C Convertible Preferred Stock, 34,461 and 34,853 shares outstanding, respectively | ||||||||||||||||||||
| Stockholders’ equity (deficit): | ||||||||||||||||||||
| Common stock, $0.0001 par value; 6,000,000,000 authorized shares 820,712,103 and 768,031,041 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities, mezzanine and stockholders’ equity | ||||||||||||||||||||
Loading...
